• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强脉冲光联合低强度光疗法治疗干眼症:一项为期一年随访的回顾性前后对照研究。

Combined Intense Pulsed Light and Low-Level Light Therapy for the Treatment of Dry Eye: A Retrospective Before-After Study with One-Year Follow-Up.

作者信息

Pérez-Silguero Miguel Angel, Pérez-Silguero David, Rivero-Santana Amado, Bernal-Blasco Maria Inmaculada, Encinas-Pisa Pablo

机构信息

Department of Ophthalmology, La Paloma Hospital, Las Palmas de Gran Canaria, Canary Islands, Spain.

Department of Ophthalmology, Pérez-Silguero Ophthalmologic Clinic, Las Palmas de Gran Canaria, Canary Islands, Spain.

出版信息

Clin Ophthalmol. 2021 May 21;15:2133-2140. doi: 10.2147/OPTH.S307020. eCollection 2021.

DOI:10.2147/OPTH.S307020
PMID:34045848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8149274/
Abstract

PURPOSE

To assess the effectiveness of a combination of intense pulsed light and low-level light therapy (IPL/LLLT) for the treatment of dry eye.

STUDY DESIGN

Retrospective before-after single-center clinical study.

MATERIALS AND METHODS

Patients diagnosed with dry eye, refractory to conventional treatment, underwent four sessions of combined IPL/LLLT over 3 months. The Ocular Surface Disease Index (OSDI) questionnaire, non-invasive breakup time (NIBUT), tear film osmolarity and meniscus height were measured 6 months before intervention, at baseline, post-intervention (3 months), 9 and 15 months.

RESULTS

NIBUT, osmolarity and meniscus height significantly worsened during the 6 months before treatment, whereas symptoms did not change. OSDI scores significantly improved at post-intervention (MD = -44.0, 95% CI -38.1, -50.0), and then increased again until the at last follow-up, but still significantly different from baseline (MD = -30.0, 95% CI -23.4, -36.8). The three clinical signs showed a similar pattern, with one-year improvements of 3.6 seconds for the NIBUT (95% CI 3.1, 4.2, p <0.001), 28 mOsm/L for osmolarity (95% CI 23.6, 32.4, p <0.001) and 0.03 mm for meniscus height (95% CI 0.02, 0.04, p <0.001). No adverse effects were observed.

CONCLUSION

IPL/LLLT is safe and produces an important reduction in symptoms and signs of dry eye disease, still relevant one year after the end of treatment in a sample with high symptoms' severity. Therefore, it represents a promising treatment option for patients who do not improve with conventional treatment. Randomized trials are needed to determine the added benefit provided by LLLT.

摘要

目的

评估强脉冲光联合低强度光疗法(IPL/LLLT)治疗干眼症的有效性。

研究设计

单中心回顾性前后对照临床研究。

材料与方法

被诊断为干眼症且对传统治疗无效的患者,在3个月内接受了4次IPL/LLLT联合治疗。在干预前6个月、基线、干预后(3个月)、9个月和15个月时,测量眼表疾病指数(OSDI)问卷、非侵入性泪膜破裂时间(NIBUT)、泪膜渗透压和泪河高度。

结果

治疗前6个月,NIBUT、渗透压和泪河高度显著恶化,而症状未改变。干预后OSDI评分显著改善(MD=-44.0,95%CI -38.1,-50.0),然后再次升高,直至最后一次随访,但仍与基线有显著差异(MD=-30.0,95%CI -23.4,-36.8)。三项临床体征呈现相似模式,NIBUT一年改善3.6秒(95%CI 3.1,...

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8149274/819befb711e1/OPTH-15-2133-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8149274/c284f2f4b068/OPTH-15-2133-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8149274/54820660f7d2/OPTH-15-2133-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8149274/a0d315fa7f5b/OPTH-15-2133-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8149274/819befb711e1/OPTH-15-2133-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8149274/c284f2f4b068/OPTH-15-2133-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8149274/54820660f7d2/OPTH-15-2133-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8149274/a0d315fa7f5b/OPTH-15-2133-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8149274/819befb711e1/OPTH-15-2133-g0004.jpg

相似文献

1
Combined Intense Pulsed Light and Low-Level Light Therapy for the Treatment of Dry Eye: A Retrospective Before-After Study with One-Year Follow-Up.强脉冲光联合低强度光疗法治疗干眼症:一项为期一年随访的回顾性前后对照研究。
Clin Ophthalmol. 2021 May 21;15:2133-2140. doi: 10.2147/OPTH.S307020. eCollection 2021.
2
Efficiency of Combining Heated Eye Mask with Intense Pulsed Light Therapy as a Treatment Option for Evaporative Dry Eye Disease.加热眼罩联合强脉冲光治疗蒸发过强型干眼症的疗效。
Rom J Ophthalmol. 2024 Apr-Jun;68(2):158-165. doi: 10.22336/rjo.2024.29.
3
Combined intense pulsed light and low-level light therapy for the treatment of refractory Meibomian gland dysfunction.联合强脉冲光和低强度光疗法治疗难治性睑板腺功能障碍
Eur J Ophthalmol. 2022 Sep 13:11206721221127206. doi: 10.1177/11206721221127206.
4
Prospective evaluation of a new intense pulsed light, thermaeye plus, in the treatment of dry eye disease due to meibomian gland dysfunction.前瞻性评估新型强脉冲光ThermaEye Plus 治疗睑板腺功能障碍引起的干眼症。
J Optom. 2021 Apr-Jun;14(2):103-113. doi: 10.1016/j.optom.2020.08.009. Epub 2020 Oct 26.
5
Intense pulsed light-based treatment for the improvement of symptoms in glaucoma patients treated with hypotensive eye drops.基于强脉冲光的治疗方法用于改善使用降眼压眼药水治疗的青光眼患者的症状。
Eye Vis (Lond). 2022 Apr 1;9(1):12. doi: 10.1186/s40662-022-00284-4.
6
Management of Glaucoma-Related Dry Eye Disease with Intense Pulsed Light: A Randomized Control Study.强脉冲光治疗青光眼相关性干眼疾病的随机对照研究
Clin Ophthalmol. 2024 Jul 15;18:2061-2072. doi: 10.2147/OPTH.S471426. eCollection 2024.
7
Comparative Evaluation in Intense Pulsed Light Therapy Combined with or without Meibomian Gland Expression for the Treatment of Meibomian Gland Dysfunction.强脉冲光治疗联合或不联合睑板腺按摩治疗睑板腺功能障碍的疗效比较。
Curr Eye Res. 2021 Aug;46(8):1125-1131. doi: 10.1080/02713683.2020.1867750. Epub 2021 Jan 18.
8
Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland Dysfunction.强脉冲联合低强度光疗法治疗睑板腺功能障碍
Clin Ophthalmol. 2021 Jun 28;15:2803-2811. doi: 10.2147/OPTH.S318885. eCollection 2021.
9
Intense pulse light therapy treatment for refractory dry eye disease due to meibomian gland dysfunction.强脉冲光疗法治疗睑板腺功能障碍所致难治性干眼。
Int Ophthalmol. 2020 May;40(5):1135-1141. doi: 10.1007/s10792-019-01278-3. Epub 2020 Jan 8.
10
Combined low level light therapy and intense pulsed light therapy for the treatment of meibomian gland dysfunction.联合低强度光疗和强脉冲光疗治疗睑板腺功能障碍
Clin Ophthalmol. 2019 Jun 11;13:993-999. doi: 10.2147/OPTH.S213664. eCollection 2019.

引用本文的文献

1
Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Cataract Surgery: A Prospective Double-Masked Randomized Controlled Clinical Trial.低强度光疗对白内障手术患者眼表参数的影响:一项前瞻性双盲随机对照临床试验。
Ophthalmol Ther. 2025 Aug 24. doi: 10.1007/s40123-025-01228-6.
2
Dry Eye Disease Management Via Technological Methods: A Systematic Review and Network Meta-analysis.通过技术方法管理干眼疾病:一项系统评价和网状Meta分析
Ophthalmol Ther. 2025 Jul 2. doi: 10.1007/s40123-025-01187-y.
3
Quantitative and qualitative assessment of evaporative dry eye post intense pulsed light therapy, a prospective study.

本文引用的文献

1
Intense Pulsed Light Therapy In The Treatment Of Meibomian Gland Dysfunction: Current Perspectives.强脉冲光疗法治疗睑板腺功能障碍:当前观点
Clin Optom (Auckl). 2019 Oct 17;11:113-126. doi: 10.2147/OPTO.S217639. eCollection 2019.
2
Efficacy and Safety of Intense Pulsed Light in Patients With Meibomian Gland Dysfunction-A Randomized, Double-Masked, Sham-Controlled Clinical Trial.强脉冲光治疗睑板腺功能障碍患者的疗效和安全性:一项随机、双盲、假对照临床试验。
Cornea. 2020 Mar;39(3):325-332. doi: 10.1097/ICO.0000000000002204.
3
Comparison of anti-inflammatory effects of intense pulsed light with tobramycin/dexamethasone plus warm compress on dry eye associated meibomian gland dysfunction.
强脉冲光治疗后蒸发型干眼的定量和定性评估:一项前瞻性研究
Indian J Ophthalmol. 2025 Apr 1;73(4):590-593. doi: 10.4103/IJO.IJO_1136_24. Epub 2024 Dec 27.
4
Intense pulsed light therapy for ocular surface diseases.强脉冲光疗法治疗眼表疾病。
Lasers Med Sci. 2024 Apr 24;39(1):111. doi: 10.1007/s10103-024-04060-9.
5
Intense pulsed light and low-level light therapy for treating meibomian gland dysfunction and evaporative dry eye.强脉冲光和低强度光疗法治疗睑板腺功能障碍和蒸发型干眼。
Indian J Ophthalmol. 2023 Dec 1;71(12):3730. doi: 10.4103/IJO.IJO_1422_23. Epub 2023 Nov 20.
6
Comparison of Light-Based Devices in the Treatment of Meibomian Gland Dysfunction.基于光的设备治疗睑板腺功能障碍的比较。
Cureus. 2023 Jul 5;15(7):e41386. doi: 10.7759/cureus.41386. eCollection 2023 Jul.
7
Efficacy of intense pulsed light therapy on signs and symptoms of dry eye disease: A meta-analysis and systematic review.强脉冲光疗法治疗干眼疾病的体征和症状的疗效:Meta 分析和系统评价。
Indian J Ophthalmol. 2023 Apr;71(4):1316-1325. doi: 10.4103/IJO.IJO_2987_22.
8
Low-Level Light Therapy in Association with Intense Pulsed Light for Meibomian Gland Dysfunction.低强度光疗法联合强脉冲光治疗睑板腺功能障碍
Clin Ophthalmol. 2022 Dec 6;16:4003-4010. doi: 10.2147/OPTH.S384360. eCollection 2022.
9
Serial Sessions of a Novel Low-Level Light Therapy Device for Home Treatment of Dry Eye Disease.用于干眼症家庭治疗的新型低强度光疗设备的系列疗程
Ophthalmol Ther. 2023 Feb;12(1):459-468. doi: 10.1007/s40123-022-00619-3. Epub 2022 Dec 9.
10
Pulsed Light Therapy in the Management of Dry Eye Disease: Current Perspectives.脉冲光疗法在干眼症治疗中的应用现状
Clin Ophthalmol. 2022 Nov 24;16:3883-3893. doi: 10.2147/OPTH.S349596. eCollection 2022.
强脉冲光与妥布霉素/地塞米松联合热敷治疗干眼相关睑板腺功能障碍的抗炎效果比较
Int J Ophthalmol. 2019 Nov 18;12(11):1708-1713. doi: 10.18240/ijo.2019.11.07. eCollection 2019.
4
Combined low level light therapy and intense pulsed light therapy for the treatment of meibomian gland dysfunction.联合低强度光疗和强脉冲光疗治疗睑板腺功能障碍
Clin Ophthalmol. 2019 Jun 11;13:993-999. doi: 10.2147/OPTH.S213664. eCollection 2019.
5
The effect of red-to-near-infrared (R/NIR) irradiation on inflammatory processes.红光至近红外光(R/NIR)照射对炎症过程的影响。
Int J Radiat Biol. 2019 Sep;95(9):1326-1336. doi: 10.1080/09553002.2019.1625464. Epub 2019 Aug 7.
6
Meibum Expressibility Improvement as a Therapeutic Target of Intense Pulsed Light Treatment in Meibomian Gland Dysfunction and Its Association with Tear Inflammatory Cytokines.强脉冲光治疗睑板腺功能障碍中改善睑脂排出作为治疗靶点及其与泪液炎症细胞因子的相关性。
Sci Rep. 2019 May 21;9(1):7648. doi: 10.1038/s41598-019-44000-0.
7
Mitochondrial cytochrome c oxidase is not the primary acceptor for near infrared light-it is mitochondrial bound water: the principles of low-level light therapy.线粒体细胞色素c氧化酶不是近红外光的主要受体——而是线粒体结合水:低强度光疗法的原理。
Ann Transl Med. 2019 Mar;7(Suppl 1):S13. doi: 10.21037/atm.2019.01.43.
8
Effect of Intense Pulsed Light Therapy on Tear Proteins and Lipids in Meibomian Gland Dysfunction.强脉冲光疗法对睑板腺功能障碍患者泪液蛋白质和脂质的影响
J Ophthalmic Vis Res. 2019 Jan-Mar;14(1):3-10. doi: 10.4103/jovr.jovr_12_18.
9
Update on the association between dry eye disease and meibomian gland dysfunction.干眼疾病与睑板腺功能障碍之间关联的最新进展。
Hong Kong Med J. 2019 Feb;25(1):38-47. doi: 10.12809/hkmj187331. Epub 2019 Jan 31.
10
Intense regulated pulse light for the meibomian gland dysfunction.强脉冲光治疗睑板腺功能障碍。
Eur J Ophthalmol. 2020 Mar;30(2):289-292. doi: 10.1177/1120672118817687. Epub 2018 Dec 4.